Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Short Interest Down 98.0% in October

Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) saw a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 800 shares, a decrease of 98.0% from the October 15th total of 39,700 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Quantum Genomics Société Anonyme Stock Performance

QNNTF remained flat at $0.10 during midday trading on Thursday. Quantum Genomics Société Anonyme has a 52-week low of $0.10 and a 52-week high of $0.10. The business’s fifty day simple moving average is $0.10 and its 200 day simple moving average is $0.10.

About Quantum Genomics Société Anonyme

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure.